CLOSEClose The Legal Intelligencer Menu
 
X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Glaxosmithkline pharmaceuticals Glaxosmithkline pharmaceuticals headquarters in Brentford, west London.Photo: Willy Barton/Shutterstock.com

A federal judge has rescinded an order granting temporary release amid the COVID-19 pandemic to a Chinese national accused of participating in a conspiracy to steal trade secrets from GlaxoSmithKline valued at $550 million.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

P.J. D'Annunzio

Reporter at the Legal Intelligencer covering public corruption, federal courts, and breaking news.

More from this author

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.